HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Ruian Ke Selected Research
Ruian Ke Research Topics
Disease
18
Infections
03/2024 - 04/2014
7
COVID-19
04/2024 - 01/2021
3
Virus Diseases (Viral Diseases)
04/2024 - 01/2021
2
Viremia
10/2023 - 01/2021
2
Breakthrough Infections
07/2022 - 09/2021
1
Human Influenza (Influenza)
01/2023
1
Inflammation (Inflammations)
01/2022
1
Acquired Immunodeficiency Syndrome (AIDS)
01/2021
1
Communicable Diseases (Infectious Diseases)
01/2021
1
Fatigue
10/2016
1
Fibrosis (Cirrhosis)
10/2016
1
Headache (Headaches)
10/2016
1
Chronic Hepatitis C
10/2016
1
Coinfection
01/2012
Drug/Important Bio-Agent (IBA)
7
Antiviral Agents (Antivirals)
IBA
11/2022 - 10/2016
4
Antigens
IBA
02/2024 - 03/2021
3
RNA (Ribonucleic Acid)
IBA
01/2023 - 10/2016
2
Monoclonal Antibodies
IBA
04/2024 - 09/2023
2
bamlanivimab
IBA
11/2022 - 09/2021
2
COVID-19 Vaccines
IBA
07/2022 - 09/2021
2
Viral RNA
IBA
01/2022 - 07/2021
2
Vaccines
IBA
01/2021 - 10/2017
2
daclatasvir
IBA
10/2016 - 04/2014
1
CD4 Antigens (CD4 Antigen)
IBA
03/2024
1
Vorinostat
FDA Link
02/2024
1
Interferon Type I
IBA
01/2022
1
Pathogen-Associated Molecular Pattern Molecules
IBA
01/2022
1
Interferons
IBA
01/2021
1
N,N'- (2,2'- (hexa- 2,4- diyne- 1,6- diylbis(oxy))bis(2,3- dihydro- 1H- indene- 2,1- diyl))bis(1- (2- cyclohexyl- 2- (2- (methylamino)propanamido)acetyl)pyrrolidine- 2- carboxamide)
IBA
01/2021
1
DNA (Deoxyribonucleic Acid)
IBA
01/2017
1
sofosbuvir drug combination ledipasvir
IBA
10/2016
1
asunaprevir
IBA
10/2016
1
Sofosbuvir
IBA
10/2016
1
Simeprevir
IBA
10/2016
1
Nucleotides
IBA
10/2016
1
Protease Inhibitors (Protease Inhibitor)
IBA
10/2016
1
Proteins (Proteins, Gene)
FDA Link
04/2014
Therapy/Procedure
8
Therapeutics
04/2024 - 01/2012
1
Art Therapy
10/2023